Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
Clinical trial NCT01782976 · WITHDRAWN
Trial details
- NCT number
- NCT01782976
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2017-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.